J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, H. Y.
Right arrow Articles by Livermore, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, H. Y.
Right arrow Articles by Livermore, D. M.
Agricola
Right arrow Articles by Chen, H. Y.
Right arrow Articles by Livermore, D. M.

The Journal of Medical Microbiology, Vol 43, Issue 4 300-309, Copyright © 1995 by Society for General Microbiology

JOURNAL ARTICLE

Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993

H. Y. Chen, M. Yuan and D. M. Livermore
Department of Medical Microbiology, London Hospital Medical College.

Antimicrobial resistance among 1991 Pseudomonas aeruginosa isolates collected at 24 UK hospitals during late 1993 was surveyed. Three-hundred and seventy-two of the isolates were resistant, or had reduced susceptibility, to some or all of azlocillin, carbenicillin, ceftazidime, imipenem and meropenem, and the mechanisms underlying their behaviour were examined. Only 13 isolates produced secondary beta-lactamases: six possessed PSE-1 or PSE-4 enzymes and seven had novel OXA enzyme types. Those with PSE types were highly resistant to azlocillin and carbenicillin whereas those with OXA enzymes were less resistant to these penicillins. Chromosomal beta-lactamase derepression was demonstrated in 54 isolates, most of which were resistant to ceftazidime and azlocillin although susceptible to carbenicillin and carbapenems. beta-Lactamase-independent "intrinsic" resistance occurred in 277 isolates and is believed to reflect some combination of impermeability and efflux. Two forms were seen: the classical type, present in 195 isolates, gave carbenicillin resistance (MIC > 128 mg/L) and reduced susceptibility to ciprofloxacin and to all beta-lactam agents except imipenem; a novel variant, seen in 82 isolates, affected only azlocillin, ceftazidime and, to a small extent, meropenem. Resistance to imipenem was largely dissociated from that to other beta-lactam agents, and probably reflected loss of D2 porin, whereas resistance to meropenem was mostly associated with intrinsic resistance to penicillins and cephalosporins. Comparison of the present results with those of a similar study in 1982 revealed significant increases in the proportions of isolates with intrinsic resistance or stable derepression (p < 0.01, chi 2 test).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
V. Dubois, C. Arpin, V. Dupart, A. Scavelli, L. Coulange, C. Andre, I. Fischer, F. Grobost, J.-P. Brochet, I. Lagrange, et al.
{beta}-Lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres)
J. Antimicrob. Chemother., May 8, 2008; (2008) dkn174v1.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
D. Girlich, T. Naas, and P. Nordmann
Regulation of class D beta-lactamase gene expression in Ralstonia pickettii.
Microbiology, September 1, 2006; 152(Pt 9): 2661 - 2672.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
C. Wang, P. Cai, D. Chang, and Z. Mi
A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum {beta}-lactamase
J. Antimicrob. Chemother., June 1, 2006; 57(6): 1261 - 1262.
[Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D. C. Griffith, E. Corcoran, D. Lofland, A. Lee, D. Cho, O. Lomovskaya, and M. N. Dudley
Pharmacodynamics of Levofloxacin against Pseudomonas aeruginosa with Reduced Susceptibility Due to Different Efflux Pumps: Do Elevated MICs Always Predict Reduced In Vivo Efficacy?
Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1628 - 1632.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
T. Naas, D. Aubert, T. Lambert, and P. Nordmann
Complex Genetic Structures with Repeated Elements, a sul-Type Class 1 Integron, and the blaVEB Extended-Spectrum {beta}-Lactamase Gene.
Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1745 - 1752.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K.-F. Kong, S. R. Jayawardena, S. D. Indulkar, A. del Puerto, C.-L. Koh, N. Hoiby, and K. Mathee
Pseudomonas aeruginosa AmpR Is a Global Transcriptional Factor That Regulates Expression of AmpC and PoxB {beta}-Lactamases, Proteases, Quorum Sensing, and Other Virulence Factors
Antimicrob. Agents Chemother., November 1, 2005; 49(11): 4567 - 4575.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
S. Lee, Y.-J. Park, M. Kim, H. K. Lee, K. Han, C. S. Kang, and M. W. Kang
Prevalence of Ambler class A and D {beta}-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea
J. Antimicrob. Chemother., July 1, 2005; 56(1): 122 - 127.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D. Girlich, T. Naas, and P. Nordmann
OXA-60, a Chromosomal, Inducible, and Imipenem-Hydrolyzing Class D {beta}-Lactamase from Ralstonia pickettii
Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4217 - 4225.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D. Aubert, D. Girlich, T. Naas, S. Nagarajan, and P. Nordmann
Functional and Structural Characterization of the Genetic Environment of an Extended-Spectrum {beta}-Lactamase blaVEB Gene from a Pseudomonas aeruginosa Isolate Obtained in India
Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3284 - 3290.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
L. Poirel, E. Lebessi, M. Castro, C. Fevre, M. Foustoukou, and P. Nordmann
Nosocomial Outbreak of Extended-Spectrum {beta}-Lactamase SHV-5-Producing Isolates of Pseudomonas aeruginosa in Athens, Greece
Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2277 - 2279.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
G. F. Weldhagen, L. Poirel, and P. Nordmann
Ambler Class A Extended-Spectrum {beta}-Lactamases in Pseudomonas aeruginosa: Novel Developments and Clinical Impact
Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2385 - 2392.
[Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
F. Bert, Z. Ould-Hocine, M. Juvin, V. Dubois, V. Loncle-Provot, V. Lefranc, C. Quentin, N. Lambert, and G. Arlet
Evaluation of the Osiris Expert System for Identification of {beta}-Lactam Phenotypes in Isolates of Pseudomonas aeruginosa
J. Clin. Microbiol., August 1, 2003; 41(8): 3712 - 3718.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. D. Cavallo, P. Plesiat, G. Couetdic, F. Leblanc, R. Fabre, and Groupe d'Etude de la Resistance de Pseudomonas aer
Mechanisms of {beta}-lactam resistance in Pseudomonas aeruginosa: prevalence of OprM-overproducing strains in a French multicentre study (1997)
J. Antimicrob. Chemother., December 1, 2002; 50(6): 1039 - 1043.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
F. Bert, C. Branger, and N. Lambert-Zechovsky
Identification of PSE and OXA {beta}-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism
J. Antimicrob. Chemother., July 1, 2002; 50(1): 11 - 18.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
Q. Li, J. Y. Lee, R. Castillo, M. S. Hixon, C. Pujol, V. R. Doppalapudi, H. M. Shepard, G. M. Wahl, T. J. Lobl, and M. F. Chan
NB2001, a Novel Antibacterial Agent with Broad-Spectrum Activity and Enhanced Potency against {beta}-Lactamase-Producing Strains
Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1262 - 1268.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
V. Dubois, L. Poirel, C. Marie, C. Arpin, P. Nordmann, and C. Quentin
Molecular Characterization of a Novel Class 1 Integron Containing blaGES-1 and a Fused Product of aac(3)-Ib/aac(6"")-Ib"" Gene Cassettes in Pseudomonas aeruginosa
Antimicrob. Agents Chemother., March 1, 2002; 46(3): 638 - 645.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D. Aubert, L. Poirel, J. Chevalier, S. Leotard, J.-M. Pages, and P. Nordmann
Oxacillinase-Mediated Resistance to Cefepime and Susceptibility to Ceftazidime in Pseudomonas aeruginosa
Antimicrob. Agents Chemother., June 1, 2001; 45(6): 1615 - 1620.
[Abstract] [Full Text]

Home page
 J. Clin. Microbiol.Home page
V. Dubois, C. Arpin, M. Melon, B. Melon, C. Andre, C. Frigo, and C. Quentin
Nosocomial Outbreak Due to a Multiresistant Strain of Pseudomonas aeruginosa P12: Efficacy of Cefepime-Amikacin Therapy and Analysis of {beta}-Lactam Resistance
J. Clin. Microbiol., June 1, 2001; 39(6): 2072 - 2078.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
L. Poirel, D. Girlich, T. Naas, and P. Nordmann
OXA-28, an Extended-Spectrum Variant of OXA-10 {beta}-Lactamase from Pseudomonas aeruginosa and Its Plasmid- and Integron-Located Gene
Antimicrob. Agents Chemother., February 1, 2001; 45(2): 447 - 453.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
H. Pai, J.-W. Kim, J. Kim, J. H. Lee, K. W. Choe, and N. Gotoh
Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical Isolates
Antimicrob. Agents Chemother., February 1, 2001; 45(2): 480 - 484.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
O. Lomovskaya, M. S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, et al.
Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa: Novel Agents for Combination Therapy
Antimicrob. Agents Chemother., January 1, 2001; 45(1): 105 - 116.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
A. Brooun, S. Liu, and K. Lewis
A Dose-Response Study of Antibiotic Resistance in Pseudomonas aeruginosa Biofilms
Antimicrob. Agents Chemother., March 1, 2000; 44(3): 640 - 646.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
O. Lomovskaya, A. Lee, K. Hoshino, H. Ishida, A. Mistry, M. S. Warren, E. Boyer, S. Chamberland, and V. J. Lee
Use of a Genetic Approach To Evaluate the Consequences of Inhibition of Efflux Pumps in Pseudomonas aeruginosa
Antimicrob. Agents Chemother., June 1, 1999; 43(6): 1340 - 1346.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
F. Danel, L. M. C. Hall, B. Duke, D. Gur, and D. M. Livermore
OXA-17, a Further Extended-Spectrum Variant of OXA-10 beta -Lactamase, Isolated from Pseudomonas aeruginosa
Antimicrob. Agents Chemother., June 1, 1999; 43(6): 1362 - 1366.
[Abstract] [Full Text]

Home page
 J. Clin. Microbiol.Home page
H. Pai, S. Lyu, J. H. Lee, J. Kim, Y. Kwon, J.-W. Kim, and K. W. Choe
Survey of Extended-Spectrum beta -Lactamases in Clinical Isolates of Escherichia coli and Klebsiella pneumoniae: Prevalence of TEM-52 in Korea
J. Clin. Microbiol., June 1, 1999; 37(6): 1758 - 1763.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
T. Naas, L. Philippon, L. Poirel, E. Ronco, and P. Nordmann
An SHV-Derived Extended-Spectrum beta -Lactamase in Pseudomonas aeruginosa
Antimicrob. Agents Chemother., May 1, 1999; 43(5): 1281 - 1284.
[Abstract] [Full Text]

Home page
 J Antimicrob ChemotherHome page
D. M. Livermore and H. Y. Chen
Quality of antimicrobial susceptibility testing in the UK: a Pseudomonas aeruginosa survey revisited
J. Antimicrob. Chemother., April 1, 1999; 43(4): 517 - 522.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
I. Ziha-Zarifi, C. Llanes, T. Köhler, J.-C. Pechere, and P. Plesiat
In Vivo Emergence of Multidrug-Resistant Mutants of Pseudomonas aeruginosa Overexpressing the Active Efflux System MexA-MexB-OprM
Antimicrob. Agents Chemother., February 1, 1999; 43(2): 287 - 291.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
T. Köhler, M. Michea-Hamzehpour, S. F. Epp, and J.-C. Pechere
Carbapenem Activities against Pseudomonas aeruginosa: Respective Contributions of OprD and Efflux Systems
Antimicrob. Agents Chemother., February 1, 1999; 43(2): 424 - 427.
[Abstract] [Full Text]

Home page
 J Antimicrob ChemotherHome page
K. Marumo, A. Takeda, Y. Nakamura, and K. Nakaya
Detection of OXA-4 {beta}-lactamase in Pseudomonas aeruginosa isolates by genetic methods
J. Antimicrob. Chemother., February 1, 1999; 43(2): 187 - 193.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
F. Danel, L. M. C. Hall, D. Gur, and D. M. Livermore
OXA-16, a Further Extended-Spectrum Variant of OXA-10 beta -Lactamase, from Two Pseudomonas aeruginosa Isolates
Antimicrob. Agents Chemother., December 1, 1998; 42(12): 3117 - 3122.
[Abstract] [Full Text]

Home page
 J. Clin. Microbiol.Home page
H. Vahaboglu, R. Ozturk, H. Akbal, S. Saribas, and O. Tansel
Practical Approach for Detection and Identification of OXA-10-Derived Ceftazidime-Hydrolyzing Extended-Spectrum beta -Lactamases
J. Clin. Microbiol., March 1, 1998; 36(3): 827 - 829.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 1995 Society for General Microbiology.